Which companies developing cancer drugs are attractive takeover targets? Seeking Alpha analysts offer their picks. Read more here.

Victoria’s VoxCell BioInnovation and game developer Kano were among the hundreds of firms at Web Summit Vancouver this week ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Merck MRK and Pfizer PFE are leading pharmaceutical companies with strong product and pipeline portfolios in oncology. Both companies also have presences in vaccines, neuroscience, and immunology.

Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.

Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the ...

Stocks of cancer treatment developers will be moving into the spotlight later this week when the annual meeting of the ...

Companies remain exposed to heightened risks between the world’s largest markets and are cautious of the stability of ...

Here we highlight a subset of our preferred stocks from the screener. Overview: The Oncology Institute, Inc. is a U.S.-based company offering a range of medical oncology services with a market cap ...

Introduction Oncology drugs are medications used to prevent or treat cancer. These include chemotherapy, targeted therapy, immunotherapy, and h ...